Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care
Recruiting · NCT06648733 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital Muenster
View the official record on ClinicalTrials.gov →Interventions studied
Structured pharmaceutical discharge management
What this trial is about
The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.):
- advanced, malignant tumour disease
- advanced, chronic obstructive pulmonary disease
- Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form
Exclusion criteria
- Impossibility of understanding the information and declaration of consent.
Where it is running
1 location listed.
- University Hospital Muenster - Münster, North Rhine-Westphalia, Germany